Literature DB >> 29587256

Protein Biomarkers in Asthma.

Alexander V Karaulov1,2, Victoria Garib2,3, Firuz Garib1,4,5, Rudolf Valenta2,3,6.   

Abstract

Asthma is a chronic disabling respiratory disease that can be triggered by a variety of factors, including allergens, respiratory infections, psychological factors, occupational agents, exercise, atmospheric pollutants, and drugs. The asthma syndrome has been treated for decades according to a "one-fits-all" treatment strategy based on bronchodilators and steroids. With the availability of new forms of treatment targeting the different pathomechanisms of the asthma syndrome, such as anti-immunoglobulin E and cytokine-targeting therapies, the interest in biomarkers that can dis criminate different forms of asthma according to their pathomechanisms has increased. This review attempts to provide an overview of protein biomarkers in asthma and how they might be used to discriminate different forms of asthma that may respond positively to sophisticated new targeted therapies.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Allergy; Asthma; Biomarkers; Molecular allergology

Mesh:

Substances:

Year:  2018        PMID: 29587256     DOI: 10.1159/000486856

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

Review 1.  Current Insights on the Impact of Proteomics in Respiratory Allergies.

Authors:  Juan Carlos Vizuet-de-Rueda; Josaphat Miguel Montero-Vargas; Miguel Ángel Galván-Morales; Raúl Porras-Gutiérrez-de-Velasco; Luis M Teran
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 2.  Microarray-Based Allergy Diagnosis: Quo Vadis?

Authors:  Huey-Jy Huang; Raffaela Campana; Oluwatoyin Akinfenwa; Mirela Curin; Eszter Sarzsinszky; Antonina Karsonova; Ksenja Riabova; Alexander Karaulov; Katarzyna Niespodziana; Olga Elisyutina; Elena Fedenko; Alla Litovkina; Evgenii Smolnikov; Musa Khaitov; Susanne Vrtala; Thomas Schlederer; Rudolf Valenta
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

3.  Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma.

Authors:  Veronika Naumova; Evgeny Beltyukov; Katarzyna Niespodziana; Peter Errhalt; Rudolf Valenta; Alexander Karaulov; Darina Kiseleva
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.